Modifiers of Symptomatic Embolic Risk in Infective Endocarditis

OBJECTIVE: To ascertain the impact of prior antiplatelet and statin therapy on symptomatic embolic events in native valve infective endocarditis (IE). PATIENTS AND METHODS: We studied a retrospective cohort of adult patients with a diagnosis of IE who presented to Mayo Clinic (Rochester, MN) from Ja...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Anavekar, Nandan S., Schultz, Jason C., De Sa, Daniel D. Correa, Thomas, Justin M., Lahr, Brian D., Tleyjeh, Imad M., Steckelberg, James M., Wilson, Walter R., Baddour, Larry M.
Format: Artigo
Idioma:Inglês
Publicat: Mayo Foundation for Medical Education and Research 2011
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3202997/
https://ncbi.nlm.nih.gov/pubmed/22033251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4065/mcp.2011.0111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars